Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jacob Hauser"'
Autor:
Jacqueline Dulanto, David Chu, Pardis Saffari, Mina Abdelshahid, Prissilla Xu, Jacob Hauser, Jonathan Eskenazi, Lynnea Morm, Antonio K Liu
Publikováno v:
Cureus.
Autor:
Barak Shoshany, Jacob Hauser
If time travel is possible, it seems to inevitably lead to paradoxes. These include consistency paradoxes, such as the famous grandfather paradox, and bootstrap paradoxes, where something is created out of nothing. One proposed class of resolutions t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2688cd0e4a5210accbe383cb48ac9b43
Autor:
Paula L. Miliani De Marval, Fabiane Sônego, Thi Bui, Robin Ball, Ian Belle, Elizabeth Reap, Emily O’Koren, Kader Thiam, Martin Gaëlle, Jacob Hauser, Chassidy Hall, Anya Avrutskaya
Publikováno v:
Cancer Research. 80:5635-5635
Targeting CTLA-4 has shown remarkable long-term benefits and thus remains a valuable approach for combating cancers of many types. A number of preclinical models have been developed over the years to evaluate the efficacy of immune checkpoint blockad
Autor:
Patrick Fadden, Ian Belle, Kelli Davis, Katherine Krontz, David Harris, Na Li, David Hurtado, Kyle Takayama, Edgar Wood, Cristina Sokolowski, Paula L. Miliani De Marval, Thi Bui, Jacob Hauser
Publikováno v:
Molecular Cancer Therapeutics. 18:A015-A015
The clinical success of immune checkpoint therapies such as PD-1, PD-L1, and CTLA-4 inhibitory antibodies has stimulated interest in a wide range of approaches to cancer immunotherapy. Development of these new modalities requires robust, well charact
Autor:
Chassidy Hall, Fabiane Sônego, Kader Thiam, Julie Chaix, Thi Bui, Gaëlle Martin, Robin Ball, Anya Avrutskaya, Paula L. Miliani De Marval, Emily O’Koren, Ian Belle, Jacob Hauser
Publikováno v:
Cancer Research. 79:LB-063
Over the past decade there has been an increasing demand in the use of syngeneic models for evaluating the efficacy of checkpoint inhibition-based cancer immunotherapies. During tumor development, immune cells can became unresponsive to the presence
Autor:
Edgar Wood, Cristina Sokolowski, Thi Bui, Kyle Takayama, David Hurtado, Ian Belle, Na Li, Patrick Fadden, Kathrine Krontz, Kelli Davis, Jacob Hauser
Publikováno v:
Cancer Research. 79:LB-060
Immune focused interventions remain a high priority for many drug discovery efforts, spurred on by the success of immune checkpoint therapies such as anti-PD-1, anti-PD-L1, and anti-CTLA-4 inhibitory antibodies. Preclinical efficacy assessments of no
Publikováno v:
Molecular Cancer Therapeutics. 14:C110-C110
Given the increasing success of cancer immunotherapies, we recognized a growing need for well-characterized preclinical models to enable drug discovery efforts. Syngeneic mouse tumor models offer advantages over conventional xenograft models for immu
Autor:
Jacob Hauser, Tracy Brainard, Aidan Synnott, Sheri Barnes, Daniel L. Small, Robert J. Mullin, Paula L. Miliani De Marval
Publikováno v:
Cancer Research. 75:3362-3362
With the increasing success and subsequent interest in tumor immunology, we recognized a growing need for well-characterized preclinical models. While the literature contains many different experimental models, the available data includes a variety o
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.